Gastroenteritis
·MeSH: Gastroenteritis
Prevalence
5.0 / 100K
6 drugs in development·3 companies·3 clinical trials
Drug Pipeline by Phase
Phase 3(3)
Phase 2(1)
| Drug | Company |
|---|---|
| hil-214 | HilleVax, Inc. (HLVX) |
Phase 1(1)
Phase 4(1)
| Drug | Company |
|---|---|
| mrna-1403 | Moderna, Inc. (MRNA) |
Compare drugs
Frequently asked questions
How many drugs are in development for Gastroenteritis?
BioSniper tracks 6 drugs in development for Gastroenteritis across 3 companies.
How many clinical trials target Gastroenteritis?
There are 3 clinical trials targeting Gastroenteritis tracked by BioSniper.
What is the prevalence of Gastroenteritis?
The estimated prevalence of Gastroenteritis is approximately 5.0 per 100,000 population.
Deep-dive into Gastroenteritis
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis